Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-22
DOI
10.3389/fmed.2020.579677
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure
- (2020) Markus Trieb et al. JOURNAL OF HEPATOLOGY
- Cardiovascular Insufficiency, Abdominal Sepsis, and Patients’ Age Are Associated with Decreased Paraoxonase-1 (PON1) Activity in Critically Ill Patients with Multiple Organ Dysfunction Syndrome (MODS)
- (2019) Iwona Bednarz-Misa et al. DISEASE MARKERS
- High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients
- (2019) Sébastien Tanaka et al. Annals of Intensive Care
- Biological consequences of dysfunctional HDL
- (2018) Angela Prillo et al. CURRENT MEDICINAL CHEMISTRY
- HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients
- (2018) Kathrin Untersteller et al. JOURNAL OF LIPID RESEARCH
- HDL Cholesterol Efflux is Impaired in Older Patients with Early Sepsis
- (2018) Faheem W. Guirgis et al. SHOCK
- Counting Sepsis, an Imprecise but Improving Science
- (2017) Kristina E. Rudd et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis
- (2017) Mihai Cirstea et al. JOURNAL OF CRITICAL CARE
- Low HDL levels in sepsis versus trauma patients in intensive care unit
- (2017) Sébastien Tanaka et al. Annals of Intensive Care
- Cholesterol efflux capacity: An introduction for clinicians
- (2016) Malcolm Anastasius et al. AMERICAN HEART JOURNAL
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Apolipoprotein A-V is not a major determinant of triglyceride levels during human sepsis
- (2015) Kanchana Ngaosuwan et al. JOURNAL OF CRITICAL CARE
- Dialysis Modalities and HDL Composition and Function
- (2015) M. Holzer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- HDL particle number and size as predictors of cardiovascular disease
- (2015) Anatol Kontush Frontiers in Pharmacology
- HDL in innate and adaptive immunity
- (2014) A. L. Catapano et al. CARDIOVASCULAR RESEARCH
- Hepatic Scavenger Receptor BI Protects Against Polymicrobial-induced Sepsis through Promoting LPS Clearance in Mice
- (2014) Ling Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis
- (2014) Alexandra Lekkou et al. JOURNAL OF CRITICAL CARE
- Albumin Replacement in Patients with Severe Sepsis or Septic Shock
- (2014) Pietro Caironi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology
- (2014) Ruth Birner-Gruenberger et al. PROGRESS IN LIPID RESEARCH
- PCSK9 is a critical regulator of the innate immune response and septic shock outcome
- (2014) K. R. Walley et al. Science Translational Medicine
- High Density Lipoprotein Protects against Polymicrobe-induced Sepsis in Mice
- (2013) Ling Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients*
- (2012) Nathalie Layios et al. CRITICAL CARE MEDICINE
- Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial*
- (2011) Jens U. Jensen et al. CRITICAL CARE MEDICINE
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
- (2010) Margarita de la Llera-Moya et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis
- (2010) INTENSIVE CARE MEDICINE
- Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2
- (2010) Wijtske Annema et al. JOURNAL OF LIPID RESEARCH
- Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans
- (2009) Laura Calabresi et al. CIRCULATION
- Decreased paraoxonase activity in critically ill patients with sepsis
- (2009) Frantisek Novak et al. CLINICAL AND EXPERIMENTAL MEDICINE
- The paraoxonases: role in human diseases and methodological difficulties in measurement
- (2009) Jordi Camps et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation
- (2009) Stefan Barlage et al. INTENSIVE CARE MEDICINE
- Multiple actions of high-density lipoprotein
- (2008) Matilda Florentin et al. CURRENT OPINION IN CARDIOLOGY
- Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid
- (2008) Yan-ling Jiao et al. CYTOKINE
- Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N-(3-Oxododecanoyl)-L-Homoserine Lactone
- (2008) J. F. Teiber et al. INFECTION AND IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started